Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations of a HIF hydroxylase inhibitor

Pharmaceutical formulations of a HIF hydroxylase inhibitor

US Patent 10765672 · Granted Sep 8, 2020

Estimated economic value: $46,638,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhanced erythropoiesis and iron metabolism2023
Nitrogen-containing heteroaryl compounds and methods of use thereof2022
Enhanced erythropoiesis and iron metabolism2021
Nitrogen-containing heteroaryl compounds and methods of use thereof2020
Crystalline forms of a prolyl hydroxylase inhibitor2019
Crystalline forms of a prolyl hydroxylase inhibitor2018
Nitrogen-containing heteroaryl compounds and methods of use thereof2018
Crystalline forms of a prolyl hydroxylase inhibitor2018
Methods of treating chronic rhinosinusitis2017
Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydrox2017
Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carb2017
Crystalline forms of a prolyl hydroxylase inhibitor2017